Bright sparks in the biomedical sector

Singapore-based biotechnology firm Tessa Therapeutics (Tessa) has come a long way from the Singapore cafe where the idea of its inception was hatched.

Born over a discussion eight years ago between an immunologist and an oncologist, it is today ahead in the race to turn cancer patients' own immune cells (T-cells) against the tumours in their bodies.


Thank you for reading The Straits Times

You have reached one of our Premium stories. To continue reading, get access now or log in if you are a subscriber.

What is Premium?

A version of this article appeared in the print edition of The Sunday Times on March 04, 2018, with the headline 'Bright sparks'. Print Edition | Subscribe